From antibodies to X-rays: an overview of patent eligibility in Canada
The trend for deciding patentability based on subject-matter eligibility is growing. David Schwartz and Sanro Zlobec of Smart & Biggar look at the situation in Canada, where the relevant jurisprudence remains scant
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: